Jobs / United States / Strand Therapeutics INC
Senior Vice President of Regulatory Sciences
Strand Therapeutics INC · 🇺🇸 Boston, Massachusetts
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 8 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest May 2026) — the step every H-1B hire needs first. USCIS also records 1 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Strand Therapeutics INC
The US Department of Labor certified 8 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest May 2026) — the step every H-1B hire needs first. USCIS also records 1 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Strand Therapeutics INC →
About the role
Company Overview: Strand Therapeutics is a clinical-stage biotechnology company pioneering programmable mRNA therapeutics to unlock the full potential of genetic medicines. Strand is applying its proprietary Signal Stack platform, which integrates EverScript circular RNA, AmpliScript self-replicating RNA, SignalPath targeted delivery, and logic-driven SignalLock genetic circuits to enable precise control of therapeutic activity across tissues and cell types and overcome foundational limitations in targeting, durability, and safety. Strand is advancing a pipeline with an initial focus on oncology and autoimmune disease. Its initial program, STX-001, an intratumorally delivered LNP-encapsulated self-replicating RNA expressing IL-12, has demonstrated preliminary evidence of systemic immune activation and anti-tumor activity in patients with advanced solid tumors who have progressed on prior therapies. Building on this early clinical validation, intravenously delivered STX-003 is designed for tumor-targeted expression and avoidance of off-target expression. STX-003, which is expected to enter the clinic in mid-2026, has the potential to be a major step forward for the fields of genetic medicine and oncology. Strand is also advancing STX-005, an in vivo CAR-T program designed to enable controlled, durable expression and repeat dosing. Founded by MIT synthetic biology pioneers, Strand has raised over $250 million and is headquartered in Boston, MA. Become the next standout single strand! Job Summary: Strand is looking to build a team that understands the value of working at a start-up. Joining Strand now places you alongside the founding executive team and world-leading advisors. We are looking for people who have the enthusiasm and motivation to be a highly contributing member of a small but extremely productive team. This opportunity will offer the employee the ability to work closely with the founding team and be a part of the growth strategy of the company. We are looking for a highly motivated and enthusiastic leader for the role of Senior Vice President of Regulatory Sciences. Reporting to the President, Co-Founder & Head of R&D, the Senior Vice President of Regulatory Sciences will build Strand’s internal regulatory capabilities from the ground up. This individual will shape how we engage with domestic and global health authorities, and directly influence the pace at which we bring transformative therapies to patients. This is a highly visible role that sits at the intersection of science, strategy and execution – ideal for a leader who thrives in a fast-moving, collaborative biotech environment. Primary Responsibilities: • Build and lead the Regulatory Sciences function – including Global Strategy, CMC, Operations and vendor management – with a focus on scalability, speed and scientific depth. • Own and evolve regulatory strategy for our clinical and preclinical programs, using creative, data-driven approaches that align with the scientific core of our technology. • Serve as the company’s voice in all regulatory interactions, preparing and leading health authority meetings, including FDA (CBER), TGA, EMA and other agencies. • Shape early development decisions by partnering closely with R&D, Clinical, and Technical Operations to ensure our data packages and study designs are regulatory-ready. • Drive innovation in regulatory science to support accelerated development paths, novel mechanisms, and next-gen therapeutic modalities. • Be a trusted thought partner to senior leadership, contributing to portfolio prioritization, risk management, and long-range development planning. • Foster a culture of collaboration and curiosity, mentoring teams to think strategically about regulatory science while remaining agile and pra